Baxter International (BAX) Stock: Buy, Sell, or Hold?

BAX - Baxter International Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$24.70
0.19 (0.78%) ▲
5d: -0.4%
30d: +4.31%
90d: +13.98%
WAIT
LOW Confidence
Protect Your BAX Gains
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 29, 2026 6d
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Oct 16, 2026 at $25.04 · last confirmed Oct 20, 2026

Strength: 5.9/10

Get Alerted When BAX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: BAX is fairly priced but lacks strong directional signals. At 6.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$10.46
Based on -11.9% avg growth
INTRINSIC VALUE TODAY
$6.49
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BAX is currently trading at $24.70, which is considered slightly high relative to its 30-day fair value range of $23.29 to $24.74. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.1) compared to its historical average (10.1). At these levels, the market is pricing in 6.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, BAX is in a strong downtrend. Immediate support is located at $23.50, while resistance sits at $25.98.

Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.92 (+13.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $23.29 - $24.74
Company Quality Score 43/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 61.9%

Protect Your Profits

Holding BAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Mixed technical signals (46/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($27.92)
  • NEUTRAL: Trading at premium valuation - market expects 6.3% growth which is achievable
  • WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $23.29 - $24.74
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $23.50
Resistance Level $25.99
Current Trend Strong Downtrend
Technical data as of Oct 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 12.11
Wall Street Target $27.92 (+13.0%)
Revenue Growth (YoY) 5.3%
Earnings Growth (YoY) 36.8%
Profit Margin -9.3%
Valuation Premium vs History +6.3% premium
PE vs Historical 12.1 vs 10.1 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.3% (market-implied from PE analysis)
1-Year Target $26.26 (+6%)
2-Year Target $27.91 (+13%)
3-Year Target $29.67 (+20%)
3-Yr Target (if PE normalizes) (PE: 12→10) PE COMPRESSION $24.74 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: -27.9%) $40.17 (+63%)
Base: (SPY PE: 12.1, Growth: -27.9%) $24.49 (-1%)
Bear: (PE: 10.1, Growth: -27.9%) $20.43 (-17%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 22, 2026 7:05 AM ET
Data refreshes hourly during market hours. Next update: 8:05 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BAX.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
STRONG BUY
34 analysts
$479 41 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$83 45 HOLD
RGEN
Repligen Corporation
STRONG BUY
22 analysts
$198 53 HOLD
WST
West Pharmaceutical Servâ€Ļ
STRONG BUY
17 analysts
$413 37 SELL
STVN
Stevanato Group SpA
BUY
14 analysts
$24 67 BUY

Advanced BAX Option Strategies

Professional options setups generated by AI based on today's BAX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BAX

BAX Technical Chart BAX Price Prediction BAX Earnings Date BAX Investment Advisor BAX Fair Price Analyzer BAX Options Advisor BAX Options Chain BAX Options Analysis BAX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals